US-Pharmakonzern: Merck & Co übernimmt Prometheus Biosciences für 10,8 Milliarden Dollar
Um den Bereich der Immunologie voranzubringen, sagte Merck & Co dem Kauf des Biotech-Unternehmens jetzt offiziell zu. Knapp 11 Milliarden…
101,930$
-0,38%
Echtzeit-Aktienkurs Merck & Co. Inc.
Bid:
Ask:
Nachrichten zur Merck & Co. Inc. Aktie
US-Pharmakonzern: Merck & Co will Prometheus Biosciences übernehmen
Prometheus Biosciences und Merck & Co befinden sich Berichten zufolge in fortgeschrittenen Gesprächen zum Kauf. Die Übernahme könne allerdings auch…
UPDATE 1-Merck in late-stage talks to acquire Prometheus Biosciences - WSJ
...(Adds details and background)
April 16 (Reuters) - Merck & Co....
Merck and Prometheus did not immediately respond to a
Reuters request......…
Merck in late-stage talks to acquire Prometheus Biosciences -WSJ
...April 16 (Reuters) - Merck & Co is in late-stage
talks to acquire......…
Merck in Late-Stage Talks to Acquire Prometheus Biosciences
Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a…
Insiderhandel: Exe V-P & Pres. MMD verkauft Aktien von Merck & Company im Wert von 15.425.068$
Chattopadhyay, Sanat - Vorstand - Tag der Transaktion: 2023-04-13...…
Merck (MRK) Outpaces Stock Market Gains: What You Should Know
Merck (MRK) closed the most recent trading day at $115.58, moving +1.61% from the previous trading session....…
Hot Stocks: PGR drops on earnings; CNSL rises on buyout offer; MRK higher on analyst upgrade; EDIT gains; HOG slides
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
IntelGenx Announces Organizational Changes to Support Global Growth Strategy
SAINT LAURENT, Quebec, April 13, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced…
Merck: FDA to Review Expanded Keytruda Use in Metastatic Gastric Cancer >MRK
Merck: FDA to Review Expanded Keytruda Use in Metastatic Gastric Cancer >MRK...…
Merck’s stock leads the Dow’s early gainers after Citi turns bullish, raises price target by 24%
Shares of Merck & Co. Inc. MRK rose 1.1% to pace the Dow Jones Industrial Average’s DJIA premarket gainers, after…
Merck & Co: Die Schätzungen "erheblich" erhöht - Upgrade! Aktienanalyse
New York (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Analyst Andrew Baum von der Citigroup:
Andrew Baum, Analyst der Citigroup, setzt seine…
Check Out What Whales Are Doing With MRK
read more...…
Where Merck & Co Stands With Analysts
Latest Ratings for MRK
DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Jan 2022JP MorganMaintainsOverweight Dec 2021Daiwa CapitalInitiates Coverage OnNeutral
…
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could…
Merck (MRK) Keytruda Studies in Difficult-to-Treat Cancers Fail
Merck (MRK) and Eisai announce the discontinuation of the phase III LEAP-003 study seeking approval of the Keytruda and Lenvima…
Merck, Eisai Announce Disappointing Results From Phase 3 LEAP-003 And LEAP-017 Trials
KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) and Eisai Co., Ltd. announced that Phase 3 LEAP-003 trial and LEAP-017 trial failed…
Merck, Eisai to discontinue late-stage study for skin cancer
...(Reuters) - Merck & Co Inc and Eisai Co Ltd said on Friday......…
UPDATE 1-Merck, Eisai to discontinue late-stage study for skin cancer
...(Adds details, background)
April 7 (Reuters) - Merck & Co Inc......…
Merck & Co., Inc.: Merck: Aiming for Health Equity and Business Success
NORTHAMPTON, MA / ACCESSWIRE / April 6, 2023 / Josette Gbemudu is motivated to ensure everyone has the chance to…
Bayer- und Merck & Co-Aktie im Minus: Bayer siegt über Merck in US-Haftungsstreit um asbesthaltiges Talkum-Puder - Millioneninvestment in Ukraine
Im Streit um die Haftung für Talkum-Puder mit Asbest-Partikeln nach der Übernahme des Konsumgütergeschäfts von Merck konnte der deutsche Pharmariese…
Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?
Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Merck (MRK), Seagen Drug Combo Gets FDA Nod for Bladder Cancer
The combination of Mercks (MRK) Keytruda and Seagens (SGEN) Padcev is the first approved immunotherapy and an antibody-drug conjugate for…
Erfolg vor Gericht: Bayer siegt gegen Merck & Co im Streit um Puder-Haftungsrisiken
Sieg für Bayer im Rechtsstreit mit der US-amerikanischen Merck & Co. Die Amerikaner hatten versucht, Haftungsrisiken an die Leverkusener abzutreten,…
Bayer erzielt einen wichtigen Erfolg in einem Rechtsstreit mit Merck & Co - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Bayer-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie der Bayer AG (ISIN: DE000BAY0017,…
Pharmabranche: Bayer siegt über Merck in US-Haftungsstreit um asbesthaltiges Talkum-Puder
Bayer hatte 2014 das Konsumgütergeschäft des US-Konkurrenten übernommen. Merck & Co hatte versucht, Haftungsrisiken an den Dax-Konzern weiterzugeben – ist…
Merck & Co Unusual Options Activity For March 29
read more...…
Merck & Co: Downgrade
Paris (www.aktiencheck.de) - Rating-Update:
Justin Smith, Analyst der Société Générale, stuft die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN:…
Merck & Co., Inc.: Amplifying the Power of Women in Chemistry
NORTHAMPTON, MA / ACCESSWIRE / March 22, 2023 / Merck & Co., Inc. For Dr. Rebecca Ruck, having more women…
Top Research Reports for Merck, Intel & MercadoLibre
Todays Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Intel Corporation (INTC)…
Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?
Strong sales of key products like Keytruda and Gardasil and positive pipeline/regulatory developments should keep Mercks (MRK) stock afloat in…
Studienrückschlag für Merck & Co - FedEx hebt Prognose an - Dividendenkürzung bei Vonovia
Wien (www.aktiencheck.de) - Auf den Papieren des US-Pharmakonzerns Merck & Co (ISIN: US58933Y1055, WKN: A0YD8Q, Ticker-Symbol: 6MK, NYSE-Symbol: MRK) lastete…
Merck’s combination therapy in lung cancer fails a Phase 2 clinical trial
Merck & Co. Inc. MRK said late Thursday that its combination therapy of vibostolimab and Keytruda did not outperform chemotherapy…
Merck & Co: Abstufung und Kurszielsenkung
San Francisco (www.aktiencheck.de) - Rating-Update:
Wells Fargo Advisors stuft die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN: A0YD8Q, Ticker-Symbol:…
XETR : DIVIDEND/INTEREST INFORMATION - 14.03.2023 - US58933Y1055
Das Instrument 6MK US58933Y1055 MERCK CO. DL-,01 EQUITY wird ex Dividende/Zinsen…
Merck & Co: Kursziel angehoben
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von Guggenheim Securities stufen die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN:…
XFRA : DIVIDEND/INTEREST INFORMATION - 14.03.2023 - US58933Y1055
Das Instrument 6MK US58933Y1055 MERCK CO. DL-,01 EQUITY wird cum Dividende/Zinsen…
Merck: Phase 2/3 CCTG IND.227/KEYNOTE-483 Trial With KEYTRUDA Meets Primary Endpoint
KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) and the Canadian Cancer Trials Group announced that the Phase 2/3 CCTG IND.227/KEYNOTE-483 trial…
Merck (MRK) Reports Detailed Data From PAH Study on Sotatercept
Merck & Co. (MRK) announces detailed data from the phase III STELLAR study of sotatercept for the treatment of pulmonary…
Merck & Co: Anlagevotum bestätigt
New York (www.aktiencheck.de) - Rating-Update:
Mara Goldstein, Analystin von Mizuho Securities USA, stuft die Aktie von Merck & Co Inc.…
Mercks MK-0616 Cuts LDL-C in Hypercholesterolemia in Phase 2b Study >MRK
Merck's MK-0616 Cuts LDL-C in Hypercholesterolemia in Phase 2b Study >MRK...…
Merck (MRK) Stock Sinks As Market Gains: What You Should Know
Merck (MRK) closed at $106.88 in the latest trading session, marking a -0.12% move from the prior day....…
Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…
Merck, AstraZeneca say FDA panel to review application for cancer drug
...March 2 (Reuters) - Merck & Co Inc and AstraZeneca PLC
said......…
Merck: Phase 3 KEYNOTE-671 Trial With KEYTRUDA Meets One Of Its Dual Primary Endpoints
KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) announced that the Phase 3 KEYNOTE-671 trial investigating KEYTRUDA met one of its dual…
Merck: Phase 3 Keytruda Study Hits Key Goal in Non-Small Cell Lung Cancer >MRK
Merck: Phase 3 Keytruda Study Hits Key Goal in Non-Small Cell Lung Cancer >MRK...…
Merck to discontinue Keytruda combination study for prostate cancer
...(Reuters) - Merck & Co on Tuesday said it will stop a late-stage......…
NVIDIA-Aktie nach Zahlen im Aufwind - Fresenius will sich auf Kerngeschäft konzentrieren
Wien (www.aktiencheck.de) - Als Reaktion auf das Zahlenwerk von Mittwochabend konnte die Aktie von NVIDIA (ISIN: US67066G1040, WKN: 918422, Ticker-Symbol:…
Merck & Co: "overweight"
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von J.P. Morgan Securities stufen die Aktie von Merck & Co Inc. (ISIN:…
Form 10-K Merck & Co., Inc. For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…